266 related articles for article (PubMed ID: 22013129)
41. The interplay between classical and alternative isoprenoid biosynthesis controls gammadelta T cell bioactivity of Listeria monocytogenes.
Begley M; Gahan CG; Kollas AK; Hintz M; Hill C; Jomaa H; Eberl M
FEBS Lett; 2004 Mar; 561(1-3):99-104. PubMed ID: 15013758
[TBL] [Abstract][Full Text] [Related]
42. Bispecific Antibody PD-L1 x CD3 Boosts the Anti-Tumor Potency of the Expanded Vγ2Vδ2 T Cells.
Yang R; Shen S; Gong C; Wang X; Luo F; Luo F; Lei Y; Wang Z; Xu S; Ni Q; Xue Y; Fu Z; Zeng L; Fang L; Yan Y; Zhang J; Gan L; Yi J; Zhou P
Front Immunol; 2021; 12():654080. PubMed ID: 34040604
[TBL] [Abstract][Full Text] [Related]
43. PD-1 checkpoint blockade enhances adoptive immunotherapy by human Vγ2Vδ2 T cells against human prostate cancer.
Nada MH; Wang H; Hussein AJ; Tanaka Y; Morita CT
Oncoimmunology; 2021; 10(1):1989789. PubMed ID: 34712512
[TBL] [Abstract][Full Text] [Related]
44. Alpaca (
Fichtner AS; Karunakaran MM; Gu S; Boughter CT; Borowska MT; Starick L; Nöhren A; Göbel TW; Adams EJ; Herrmann T
Proc Natl Acad Sci U S A; 2020 Mar; 117(12):6697-6707. PubMed ID: 32139608
[TBL] [Abstract][Full Text] [Related]
45. Gammadelta T cell immune manipulation during chronic phase of simian-human immunodeficiency virus infection [corrected] confers immunological benefits.
Ali Z; Yan L; Plagman N; Reichenberg A; Hintz M; Jomaa H; Villinger F; Chen ZW
J Immunol; 2009 Oct; 183(8):5407-17. PubMed ID: 19786533
[TBL] [Abstract][Full Text] [Related]
46. Synthesis of chiral phosphoantigens and their activity in gamma delta T cell stimulation.
Song Y; Zhang Y; Wang H; Raker AM; Sanders JM; Broderick E; Clark A; Morita CT; Oldfield E
Bioorg Med Chem Lett; 2004 Sep; 14(17):4471-7. PubMed ID: 15357974
[TBL] [Abstract][Full Text] [Related]
47. Analysis of endogenous ATP analogs and mevalonate pathway metabolites in cancer cell cultures using liquid chromatography-electrospray ionization mass spectrometry.
Jauhiainen M; Mönkkönen H; Räikkönen J; Mönkkönen J; Auriola S
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):2967-75. PubMed ID: 19665949
[TBL] [Abstract][Full Text] [Related]
48. Aminobisphosphonates Synergize with Human Cytomegalovirus To Activate the Antiviral Activity of Vγ9Vδ2 Cells.
Daguzan C; Moulin M; Kulyk-Barbier H; Davrinche C; Peyrottes S; Champagne E
J Immunol; 2016 Mar; 196(5):2219-29. PubMed ID: 26819204
[TBL] [Abstract][Full Text] [Related]
49. ABCA1, apoA-I, and BTN3A1: A Legitimate Ménage à Trois in Dendritic Cells.
Riganti C; Castella B; Massaia M
Front Immunol; 2018; 9():1246. PubMed ID: 29937767
[TBL] [Abstract][Full Text] [Related]
50. Rapamycin increases the yield and effector function of human γδ T cells stimulated in vitro.
Li H; Pauza CD
Cancer Immunol Immunother; 2011 Mar; 60(3):361-70. PubMed ID: 21107834
[TBL] [Abstract][Full Text] [Related]
51. Suppressive activity of Vδ2
Schilbach K; Krickeberg N; Kaißer C; Mingram S; Kind J; Siegers GM; Hashimoto H
Cancer Immunol Immunother; 2020 Apr; 69(4):593-610. PubMed ID: 31982940
[TBL] [Abstract][Full Text] [Related]
52. Anti-fibrotic characteristics of Vγ9+ γδ T cells in systemic sclerosis.
Markovits N; Bendersky A; Loebstein R; Brusel M; Kessler E; Bank I
Clin Exp Rheumatol; 2016; 34 Suppl 100(5):23-29. PubMed ID: 26886502
[TBL] [Abstract][Full Text] [Related]
53. Critical Roles for Coiled-Coil Dimers of Butyrophilin 3A1 in the Sensing of Prenyl Pyrophosphates by Human Vγ2Vδ2 T Cells.
Wang H; Nada MH; Tanaka Y; Sakuraba S; Morita CT
J Immunol; 2019 Aug; 203(3):607-626. PubMed ID: 31227581
[TBL] [Abstract][Full Text] [Related]
54. Targeting gamma delta T cells for cancer immunotherapy: bench to bedside.
Gogoi D; Chiplunkar SV
Indian J Med Res; 2013 Nov; 138(5):755-61. PubMed ID: 24434328
[TBL] [Abstract][Full Text] [Related]
55. Cutting edge: human gamma delta T cells are activated by intermediates of the 2-C-methyl-D-erythritol 4-phosphate pathway of isoprenoid biosynthesis.
Altincicek B; Moll J; Campos N; Foerster G; Beck E; Hoeffler JF; Grosdemange-Billiard C; Rodríguez-Concepción M; Rohmer M; Boronat A; Eberl M; Jomaa H
J Immunol; 2001 Mar; 166(6):3655-8. PubMed ID: 11238603
[TBL] [Abstract][Full Text] [Related]
56. Involvement of CD166 in the activation of human gamma delta T cells by tumor cells sensitized with nonpeptide antigens.
Kato Y; Tanaka Y; Hayashi M; Okawa K; Minato N
J Immunol; 2006 Jul; 177(2):877-84. PubMed ID: 16818742
[TBL] [Abstract][Full Text] [Related]
57. Identification of (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate as a major activator for human gammadelta T cells in Escherichia coli.
Hintz M; Reichenberg A; Altincicek B; Bahr U; Gschwind RM; Kollas AK; Beck E; Wiesner J; Eberl M; Jomaa H
FEBS Lett; 2001 Dec; 509(2):317-22. PubMed ID: 11741609
[TBL] [Abstract][Full Text] [Related]
58. Structure of (E)-4-hydroxy-3-methyl-but-2-enyl diphosphate reductase, the terminal enzyme of the non-mevalonate pathway.
Rekittke I; Wiesner J; Röhrich R; Demmer U; Warkentin E; Xu W; Troschke K; Hintz M; No JH; Duin EC; Oldfield E; Jomaa H; Ermler U
J Am Chem Soc; 2008 Dec; 130(51):17206-7. PubMed ID: 19035630
[TBL] [Abstract][Full Text] [Related]
59. Repeated systemic administrations of both aminobisphosphonates and human Vγ9Vδ2 T cells efficiently control tumor development in vivo.
Santolaria T; Robard M; Léger A; Catros V; Bonneville M; Scotet E
J Immunol; 2013 Aug; 191(4):1993-2000. PubMed ID: 23836057
[TBL] [Abstract][Full Text] [Related]
60. Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention.
Mo H; Elson CE
Exp Biol Med (Maywood); 2004 Jul; 229(7):567-85. PubMed ID: 15229351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
